Dr. Hugo O. Rosero, MD

Dr. Rosero practices at Mount Sinai - Brooklyn in Brooklyn, New York.

Dr. Rosero's NPI, 1346224441, was assigned on December 1, 2005. Dr. Rosero graduated from Pcom in 1986. Dr. Rosero holds New York license 1776311.

Dr. Rosero's primary practice is Mount Sinai - Brooklyn, at 3201 Kings Hwy, Brooklyn, NY 11234 in Kings County. The practice phone is (646) 605-6009.

Dr. Rosero's primary practice is Mount Sinai - Brooklyn in Brooklyn, New York. Dr. Rosero is also affiliated with Mount Sinai West. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Rosero to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosero practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rosero's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rosero is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Rosero is licensed in New York.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis and chronic hypertension among the conditions Dr. Rosero treats.

CMS data shows 1,379 Medicare services from Dr. Rosero across 13 procedure codes in 2024, for 306 Medicare patients. Medicare paid $69,146 for them.

CMS counts 306 Medicare patients who saw Dr. Rosero in 2024. The largest group is 75 to 84, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rosero's median patient age at 70, with 53% women.

In 2024, Dr. Rosero wrote 4,929 Medicare Part D claims for 733 patients. 89% of them were for generic drugs. CMS names the drug for 4,635 of them, across 57 drugs with 11 or more claims each, at $527,119 in total drug cost. In 2023, CMS named 4,726 claims across 49 drugs.

Dr. Rosero accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rosero as offering telehealth. CMS counts 13 procedures of coronary angioplasty and stenting by Dr. Rosero, more than 35% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Rosero, published from 2010 to 2013. Dr. Rosero's most frequent co-authors are Tak W. Kwan, MD, Terrence J. Sacchi, MD and Nicholas Stephen Amoroso, MD.

CMS Open Payments shows 349 general payments to Dr. Rosero from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Boston Scientific Corporation paid the most, $4,204.

Dmand AI lists 2 awards for Dr. Rosero, most recently Associate professor of medicine in 2007.

Dr. Rosero graduated from Pcom in 1986. Dr. Rosero is a member of ACC.

Dr. Rosero is in network with 17 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.